AR043133A1 - Metodo de tratamiento con nelfinavir - Google Patents

Metodo de tratamiento con nelfinavir

Info

Publication number
AR043133A1
AR043133A1 ARP040100399A ARP040100399A AR043133A1 AR 043133 A1 AR043133 A1 AR 043133A1 AR P040100399 A ARP040100399 A AR P040100399A AR P040100399 A ARP040100399 A AR P040100399A AR 043133 A1 AR043133 A1 AR 043133A1
Authority
AR
Argentina
Prior art keywords
nelfinavir
treatment method
hiv
mammal
treatment
Prior art date
Application number
ARP040100399A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR043133A1 publication Critical patent/AR043133A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Método para tratar el virus de la inmunodeficiencia humana (HIV) en un mamífero, que comprende administrar a un mamífero que lo necesite una cantidad terapéuticamente eficaz de nelfinavir en una composición farmacéutica, en el que el nelfinavir se administra con alimentos. Una composición terapéutica para el tratamiento del HIV que comprende grasa y nelfinavir en una relación de peso de al menos 25:1.
ARP040100399A 2003-02-10 2004-02-09 Metodo de tratamiento con nelfinavir AR043133A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44644403P 2003-02-10 2003-02-10
US52425803P 2003-11-21 2003-11-21

Publications (1)

Publication Number Publication Date
AR043133A1 true AR043133A1 (es) 2005-07-20

Family

ID=32853430

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100399A AR043133A1 (es) 2003-02-10 2004-02-09 Metodo de tratamiento con nelfinavir

Country Status (13)

Country Link
EP (1) EP1605942A1 (es)
JP (1) JP2006517221A (es)
AR (1) AR043133A1 (es)
BR (1) BRPI0407174A (es)
CA (1) CA2515095A1 (es)
CL (1) CL2004000202A1 (es)
MX (1) MXPA05008425A (es)
NL (1) NL1025449C2 (es)
PA (1) PA8595301A1 (es)
PE (1) PE20040948A1 (es)
TW (1) TW200423922A (es)
UY (1) UY28183A1 (es)
WO (1) WO2004069251A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157455B2 (en) 2003-02-10 2007-01-02 Hoffmann-La Roche Inc. 4-Aminopyrimidine-5-one derivatives

Also Published As

Publication number Publication date
MXPA05008425A (es) 2005-10-19
NL1025449A1 (nl) 2004-08-12
CL2004000202A1 (es) 2005-03-18
TW200423922A (en) 2004-11-16
PA8595301A1 (es) 2005-08-04
CA2515095A1 (en) 2004-08-19
NL1025449C2 (nl) 2005-03-15
UY28183A1 (es) 2004-09-30
PE20040948A1 (es) 2004-12-27
JP2006517221A (ja) 2006-07-20
EP1605942A1 (en) 2005-12-21
WO2004069251A1 (en) 2004-08-19
BRPI0407174A (pt) 2006-02-07

Similar Documents

Publication Publication Date Title
BRPI0513200A (pt) uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas
ES2190472T3 (es) Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno.
EA200300628A1 (ru) Соединения, специфические к аденозиновому a, aи aрецептору, и их применение
AR045783A1 (es) Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide
AR065580A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
CO5590913A2 (es) Terapia de combinacion antivirica
RU2013123646A (ru) Комбинированная композиция
EA200600817A1 (ru) Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты)
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
AR052830A1 (es) Regimen de cladribina para tratar esclerosis multiple
PE20211199A1 (es) Uso de reboxetina para el tratamiento de narcolepsia
AR065582A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
AR048806A1 (es) Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio
PE20031047A1 (es) Tratamiento de padecimientos post-menopausicos en pacientes con cancer de mama
AR043133A1 (es) Metodo de tratamiento con nelfinavir
PT1220676E (pt) Prevencao do cancro colorrectal
CN105362919A (zh) 一种外治寒湿痹证的中药制剂
RU2013129824A (ru) Новое лечение инфекции вируса гепатита с
AR045070A1 (es) Preparados farmaceuticos topicos de acido ascorbico con efecto post-antimicotico
AR029160A1 (es) El uso del interferon-alfa pegilado para la preparacion de un medicamento para el tratamiento del carcinoma de celula renal, un kit y el uso del mismo
AR047154A1 (es) Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol
DOP2004000815A (es) Metodo de tratamiento con nelfinavir
AR061046A1 (es) Mirtazapina para el tratamiento del dolor neuropatico
AR045178A1 (es) Uso de un componente retinoide seleccionado entre el grupo formado por agentes retinoides activos, precursores de agentes retinoides activos y mezclas de los mismos, para preparar una composicion farmaceutica
AR120453A1 (es) Combinación de un inhibidor de btk y un inhibidor de mdm2 para el tratamiento del cáncer

Legal Events

Date Code Title Description
FB Suspension of granting procedure